发明名称 Modified human hepatitis C virus genomic RNA that can be autonomously replicated
摘要 The present invention provides modified hepatitis C virus genomic RNA, comprising nucleotide sequences of genomic RNA portions of two or more types of hepatitis C viruses, which comprises a 5′ untranslated region, a core protein coding sequence, an E1 protein coding sequence, a p7 protein coding sequence, an E2 protein coding sequence, an NS2 protein coding sequence, an NS3 protein coding sequence, an NS4A protein coding sequence, an NS4B protein coding sequence, an NS5A protein coding sequence, an NS5B protein coding sequence, and a 3′ untranslated region, and which can be autonomously replicated. In particular, the present invention relates to modified hepatitis C virus genomic RNA, which can be autonomously replicated by substitution of the RNA sequence portion encoding NS3, NS4, NS5A, and NS5B proteins of hepatitis C virus genomic RNA with a partial RNA sequence encoding NS3, NS4, NS5A, and NS5B proteins of a JFH1 strain shown in SEQ ID NO: 1.
申请公布号 US9175269(B2) 申请公布日期 2015.11.03
申请号 US201313734630 申请日期 2013.01.04
申请人 TORAY INDUSTRIES, INC.;TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE 发明人 Wakita Takaji;Kato Takanobu;Date Tomoko;Miyamoto Michiko;Bartenschlager Ralf;Tanabe Jun-ichi;Sone Saburo
分类号 A61K39/29;C12N7/02;C12N7/00;C12N15/86;C12Q1/68;A61K48/00;A61K39/00 主分类号 A61K39/29
代理机构 Birch, Stewart, Kolasch & Birch, LLP 代理人 Birch, Stewart, Kolasch & Birch, LLP
主权项 1. A modified hepatitis C virus genomic RNA comprising genomic RNA portions of two or more strains of hepatitis C viruses, which comprises a 5′ untranslated region, a core protein coding sequence, an E1 protein coding sequence, an E2 protein coding sequence, a p7 protein coding sequence, an NS2 protein coding sequence, a partial RNA sequence encoding NS3, NS4A, NS4B, NS5A, and NS5B proteins of a JFH1 strain shown in SEQ ID NO:1, and a 3′ untranslated region, wherein said modified hepatitis C virus genomic RNA is autonomously replicated and is capable of producing infectious hepatitis C virus particles in a cultured cell system, wherein the core protein coding sequence, the E1 protein coding sequence, the E2 protein coding sequence, and the p7 protein coding sequence are from the hepatitis C virus strain of genotype 1b, wherein the NS2 protein coding sequence is from the hepatitis C virus strain selected from the group consisting of genotype 1b and genotype 2a, and wherein the 5′ untranslated region and the 3′ untranslated region are from the JFH-1 strain, wherein the hepatitis C virus strain of genotype 1b is HCV-con 1 strain.
地址 Tokyo JP